Cited by 1,294Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 207 of the 208 references it cites were found in a registry or an index.

Translational biology of osteosarcoma

Kansara, Maya, Teng, Michele W., Smyth, Mark J., Thomas, David M.·2014·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

For the past 30 years, improvements in the survival of patients with osteosarcoma have been mostly incremental. Despite evidence of genomic instability and a high frequency of chromothripsis and kataegis, osteosarcomas carry few recurrent targetable mutations, and trials of targeted agents have been generally disappointing. Bone has a highly specialized immune environment and many immune signalling pathways are important in bone homeostasis. The success of the innate immune stimulant mifamurtide in the adjuvant treatment of non-metastatic osteosarcoma suggests that newer immune-based treatments, such as immune checkpoint inhibitors, may substantially improve disease outcome.

Integrity signals

Registry

Crossref · 10.1038/nrc3838

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Self-citation
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
WHO Classification of Tumours of Soft Tissue and Bone: WHO Classification of Tumours, vol. 5
Fletcher, C. D. �., Bridge, J., Hogendoorn, P. C. W., & Mertens, F. (2013) · Cited by 3,072
WHO classification of tumours of soft tissue and bone
Fletcher, C. D. �. (2013) · Cited by 2,874
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478

Show all 208 references

Research works printed but not linked: 1

Lussier, D. M. et al. 28th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC) 162 (Society for Immunotherapy of Cancer, 2013).

Sorted by citations

Osteosarcoma
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
Update on Survival in Osteosarcoma
Anderson, M. E. (2016) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2015.08.022 · Cited by 560
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Corre, I., Verrecchia, F., Crenn, V., Rédiní, F., & Trichet, V. (2020) · Cells · doi:10.3390/cells9040976 · Cited by 494
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Gianferante, D. M., Mirabello, L. J., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 477
Comparative oncology: what dogs and other species can teach us about humans with cancer
Schiffman, J. D., & Breen, M. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0231 · Cited by 445
Review of Osteosarcoma and Current Management
Durfee, R. A., Mohammed, M., & Luu, H. H. (2016) · Rheumatology and Therapy · doi:10.1007/s40744-016-0046-y · Cited by 409
2D MXene‐Integrated 3D‐Printing Scaffolds for Augmented Osteosarcoma Phototherapy and Accelerated Tissue Reconstruction
Pan, S., Yin, J., Yu, L., Zhang, C., Zhu, Y., Gao, Y., & Chen, Y. (2019) · Advanced Science · doi:10.1002/advs.201901511 · Cited by 318
Metastatic osteosarcoma: a challenging multidisciplinary treatment
Meazza, C., & Scanagatta, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1168697 · Cited by 300
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
Lilienthal, I., & Herold, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186885 · Cited by 300
Carbohydrate-based drugs launched during 2000−2021
Cao, X., Du, X., Jiao, H., An, Q., Chen, R., Fang, P., Wang, J., & Yu, B. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.020 · Cited by 285
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Koirala, P., Roth, M. E., Gill, J., Piperdi, S., Chinai, J. M., Geller, D. S., Hoang, B. H., Park, A., Fremed, M. A., Zang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30093 · Cited by 267
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A.-K., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 286
Osteosarcoma: A comprehensive review of management and treatment strategies
Jafari, F., Javdansirat, S., Sanaie, S., Naseri, A., Shamekh, A., Rostamzadeh, D., & Dolati, S. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151654 · Cited by 253
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis
Aldiri, I., Xu, B., Wang, L., Chen, X. '., Hiler, D. J., Griffiths, L. M., Valentine, M. B., Shirinifard, A., Thiagarajan, S., Sablauer, A., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.022 · Cited by 252
Molecular genetics of osteosarcoma
Rickel, K., Fang, F., & Tao, J. (2016) · Bone · doi:10.1016/j.bone.2016.10.017 · Cited by 255
Novel Insights and Therapeutic Interventions for Pediatric Osteosarcoma
Kager, L., Tamamyan, G., & Bielack, S. (2016) · Future Oncology · doi:10.2217/fon-2016-0261 · Cited by 242
Review of a new bone tumor therapy strategy based on bifunctional biomaterials
Liao, J., Han, R., Wu, Y., & Qian, Z. (2021) · Bone Research · doi:10.1038/s41413-021-00139-z · Cited by 240
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
Moriarity, B. S., Otto, G. M., Rahrmann, E. P., Rathe, S. K., Wolf, N. K., Weg, M. T., Manlove, L. A., LaRue, R. S., Temiz, N. A., Molyneux, S. D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3293 · Cited by 244
Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
Saraf, A. J., Fenger, J. M., & Roberts, R. D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00004 · Cited by 237
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
Heymann, M.-F., Lézot, F., & Heymann, D. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.011 · Cited by 233
Bone microenvironment signals in osteosarcoma development
Alfranca, A., Martínez-Cruzado, L., Tornín, J., Abarrategi, A., Amaral, A. T., de Álava, E., Menéndez, P. R., Garcı́a-Castro, J., & Rodrı́guez, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1918-y · Cited by 224
Genetically engineered pigs as models for human disease
Perleberg, C., Kind, A., & Schnieke, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.030783 · Cited by 222
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
Zhang, Y., Wang, F., Li, M., Yu, Z., Qi, R., Ding, J., Zhang, Z., & Chen, X. (2018) · Advanced Science · doi:10.1002/advs.201700821 · Cited by 221
Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma
Liang, C., Li, F., Wang, L., Zhang, Z., Wang, C., He, B., Li, J., Chen, Z., Shaikh, A. B., Liu, J., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.015 · Cited by 217
Osteosarcoma: Cells‐of‐Origin, Cancer Stem Cells, and Targeted Therapies
Abarrategi, A., Tornín, J., Martínez-Cruzado, L., Hamilton, A., Martínez‐Campos, E., Rodrigo, J. P., González, M. V., Baldini, N., Garcı́a-Castro, J., & Rodrı́guez, R. (2016) · Stem Cells International · doi:10.1155/2016/3631764 · Cited by 211
In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles
Wang, Y., Wang, J., Hao, H., Cai, M., Wang, S., Ma, J., Li, Y., Mao, C., & Zhang, S. (2016) · ACS Nano · doi:10.1021/acsnano.6b03835 · Cited by 206
MXene-Based Hydrogels Endow Polyetheretherketone with Effective Osteogenicity and Combined Treatment of Osteosarcoma and Bacterial Infection
Yin, J., Han, Q., Zhang, J., Liu, Y., Gan, X., Xie, K., Xie, L., & Deng, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c14752 · Cited by 195
H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts
Zhang, Y., Liu, Z., Yang, X., Lu, W., Chen, Y., Lin, Y., Wang, J., Lin, S., & Yun, J. (2020) · Theranostics · doi:10.7150/thno.51245 · Cited by 187
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression
Baglio, S. R., Lagerweij, T., Pérez-Lanzón, M., Ho, X. D., Léveillé, N., Melo, S. A., Cleton-Jansen, A.-M., Jordanova, E. S., Roncuzzi, L., Greco, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2726 · Cited by 187
Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma
Liu, Y., Feng, W., Dai, Y., Bao, M., Yuan, Z., He, M., Qin, Z., Liao, S., He, J., Huang, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.709210 · Cited by 190
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial
Gomez‐Brouchet, A., Illac, C., Gilhodes, J., Bouvier, C., Aubert, S., Guinebretière, J., Marie, B., Larousserie, F., Entz‐Werlé, N., Pinieux, G. D. B. D., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1331193 · Cited by 180
TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling
Liu, W., Zhao, Y., Wang, G., Feng, S., Ge, X., Ye, W., Wang, Z., Zhu, Y., Cai, W., Bai, J., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102344 · Cited by 174
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
Morrow, J. J., Bayles, I., Funnell, A. P. W., Miller, T. E., Saiakhova, A., Lizardo, M. M., Bartels, C. F., Kapteijn, M. Y., Hung, S., Mendoza, A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4475 · Cited by 161
3D Printed Wesselsite Nanosheets Functionalized Scaffold Facilitates NIR‐II Photothermal Therapy and Vascularized Bone Regeneration
Yang, C., Ma, H., Wang, Z., Younis, M. R., Liu, C., Wu, C., Luo, Y., & Huang, P. (2021) · Advanced Science · doi:10.1002/advs.202100894 · Cited by 161
GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
Kim, M., Jung, J.-Y., Choi, S., Lee, H., Morales, L. D., Koh, J.-T., Kim, S. H., Choi, Y.-D., Choi, C., Slaga, T. J., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1239676 · Cited by 162
NIR light-assisted phototherapies for bone-related diseases and bone tissue regeneration: A systematic review
Wan, Z., Zhang, P., Lv, L., & Zhou, Y. (2020) · Theranostics · doi:10.7150/thno.49784 · Cited by 161
Immunotherapy for osteosarcoma: Where do we go from here?
Wedekind, M. F., Wagner, L. M., & Cripe, T. P. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27227 · Cited by 163
Osteosarcoma: Molecular Pathogenesis and iPSC Modeling
Lin, Y.-H., Jewell, B. E., Gingold, J., Lu, L., Zhao, R., Wang, L. L., & Lee, D.-F. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.06.004 · Cited by 150
CD163 + M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma
Han, Q., Shi, H., & Liu, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.023 · Cited by 153
Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma
Wang, X., Qin, G., Liang, X., Wang, W., Wang, Z., Liao, D., Zhong, L., Zhang, R., Zeng, Y., Wu, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14870-4 · Cited by 149
Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations
Bousquet, M., Noirot, C., Accadbled, F., de Gauzy, J. S., Castex, M., Brousset, P., & Gomez‐Brouchet, A. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw009 · Cited by 143
LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis
Fu, D., Lu, C., Qu, X., Li, P., Chen, K., Shan, L., & Zhu, X. (2019) · Aging · doi:10.18632/aging.102325 · Cited by 138
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
Marchandet, L., Lallier, M., Charrier, C., Baud’huin, M., Ory, B., & Lamoureux, F. (2021) · Cancers · doi:10.3390/cancers13040683 · Cited by 142
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
Suehara, Y., Alex, D., Bowman, A., Middha, S., Zehir, A., Chakravarty, D., Wang, L., Jour, G., Nafa, K., Hayashi, T., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4032 · Cited by 135
Engineering Single‐Atomic Iron‐Catalyst‐Integrated 3D‐Printed Bioscaffolds for Osteosarcoma Destruction with Antibacterial and Bone Defect Regeneration Bioactivity
Wang, L., Yang, Q., Huo, M., Lü, D., Gao, Y., Chen, Y., & Xu, H. (2021) · Advanced Materials · doi:10.1002/adma.202100150 · Cited by 135
TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
Lamora, A., Talbot, J., Mullard, M., Royer, B. B.-L., Rédiní, F., & Verrecchia, F. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5110096 · Cited by 141
Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment
Verrecchia, F., & Rédiní, F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00133 · Cited by 135
Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1.
Liu, C., & Lin, J. (2016) · PubMed Central · Cited by 127
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
Domoto, T., Uehara, M., Bolidong, D., & Minamoto, T. (2020) · Cells · doi:10.3390/cells9061388 · Cited by 134
D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy
Du, C., Zhou, M., Jia, F., Ruan, L., Lu, H., Zhang, J., Zhu, B., Liu, X., Chen, J., Chai, Z., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120642 · Cited by 127
Enhancing Osteosarcoma Killing and CT Imaging Using Ultrahigh Drug Loading and NIR‐Responsive Bismuth Sulfide@Mesoporous Silica Nanoparticles
Lu, Y., Li, L., Lin, Z., Li, M., Hu, X., Zhang, Y., Peng, M., Xia, H., & Han, G. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800602 · Cited by 122
Wnt signaling and Loxl2 promote aggressive osteosarcoma
Matsuoka, K., Bakiri, L., Wolff, L. I., Linder, M., Mikels, A. J., Patiño‐García, A., Lecanda, F., Hartmann, C., Sibilia, M. C., & Wagner, E. F. (2020) · Cell Research · doi:10.1038/s41422-020-0370-1 · Cited by 121
Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion
Wang, Z., Li, B., Li, S., Lin, W., Wang, Z., Wang, S., Chen, W., Shi, W., Chen, T., Zhou, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34064-4 · Cited by 123
Multifunctional magnesium incorporated scaffolds by 3D-Printing for comprehensive postsurgical management of osteosarcoma
Long, J., Zhang, W., Chen, Y., Teng, B., Liu, B., Li, H., Yao, Z., Wang, D., Li, L., Yu, X., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120950 · Cited by 120
Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation
Zhou, Z., Sun, T., Chen, F., Zuo, D., Wang, H., Hua, Y., Cai, Z., & Tan, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.031 · Cited by 118
Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes
Zhong, L., Liao, D., Li, J., Liu, W., Wang, J., Zeng, C., Wang, X., Cao, Z., Zhang, R., Li, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00414-1 · Cited by 118
Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples
Ho, X. D., Phung, P., Le, V. Q., Nguyễn, V. H., Reimann, E., Prans, E., Kõks, G., Maasalu, K., Le, N. T. N., Trinh, L. H., et al. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217736512 · Cited by 120
Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas
Zhang, Y., Cai, L., Li, D., Lao, Y., Liu, D., Li, M., Ding, J., & Chen, X. (2018) · Nano Research · doi:10.1007/s12274-018-2066-0 · Cited by 114
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
Sundara, Y. T., Kostine, M., Cleven, A. H. G., Bovée, J. V. M. G., Schilham, M. W., & Cleton-Jansen, A.-M. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1925-3 · Cited by 111
Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo
Zhu, J., Yu, W., Liu, B., Wang, Y., Shao, J., Wang, J., Xia, K., Liang, C., Fang, W., Zhou, C., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.488 · Cited by 107
M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression
Yadav, P., Subbarayalu, P., Medina, D., Nirzhor, S. S. R., Timilsina, S., Rajamanickam, S., Eedunuri, V. K., Gupta, Y. K., Zheng, S., Abdelfattah, N., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2106 · Cited by 104
Gut microbial DL-endopeptidase alleviates Crohn’s disease via the NOD2 pathway
Gao, J., Zhao, X., Hu, S., Huang, Z., Hu, M., Jin, S., Lu, B., Sun, K., Wang, Z., Fu, J., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.08.002 · Cited by 107
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines
Campbell, J., Ryan, C. J., Brough, R., Bajrami, I., Pemberton, H. N., Chong, I. Y.-S., Costa-Cabral, S., Frankum, J. R., Gulati, A., Holme, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.023 · Cited by 104
Pediatric Cancer Immunotherapy: Opportunities and Challenges
Wedekind, M. F., Denton, N. L., Chen, C., & Cripe, T. P. (2018) · Pediatric Drugs · doi:10.1007/s40272-018-0297-x · Cited by 113
Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/β-Catenin
Deng, Q., Li, P., Che, M., Liu, J., Biswas, S., Ma, G., He, L., Wei, Z., Zhang, Z., Yang, Y., et al. (2019) · eLife · doi:10.7554/elife.50208 · Cited by 103
HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
Koirala, P., Roth, M. E., Gill, J., Chinai, J. M., Ewart, M. R., Piperdi, S., Geller, D. S., Hoang, B. H., Fatakhova, Y. V., Ghorpade, M., et al. (2016) · Scientific Reports · doi:10.1038/srep31154 · Cited by 100
Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3
Sun, J., Wang, X., Fu, C., Wang, X., Zou, J., Hua, H., & Bi, Z. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-3975-1 · Cited by 99
Genome‐wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma
Smida, J., Xu, H., Zhang, Y., Baumhoer, D., Ribi, S., Kovac, M. B., von Luettichau, I., Bielack, S., O’Leary, V. B., Leib‐Mösch, C., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30778 · Cited by 98
Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells
Shao, X., Xiang, S., Chen, Y., Zhang, N., Cao, J., Zhu, H., Yang, B., Zhou, Q., Ying, M., & He, Q. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0262-4 · Cited by 98
Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease
Chen, Y., Wu, X., Li, J., Jiang, Y., Xu, K., & Su, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909408 · Cited by 96
Advances in emerging drugs for osteosarcoma
Hattinger, C. M., Fanelli, M., Tavanti, E., Vella, S., Ferrari, S. M., Picci, P., & Serra, M. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1051965 · Cited by 94
Exosomal miR-1228 From Cancer-Associated Fibroblasts Promotes Cell Migration and Invasion of Osteosarcoma by Directly Targeting SCAI
Wang, J., Wu, X., Xiao-juan, G., & Jiang, X. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15336368805108 · Cited by 94
Controlled Delivery of Curcumin and Vitamin K2 from Hydroxyapatite-Coated Titanium Implant for Enhanced in Vitro Chemoprevention, Osteogenesis, and in Vivo Osseointegration
Sarkar, N., & Bose, S. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22474 · Cited by 94
Fabrication of a hydroxyapatite-PDMS microfluidic chip for bone-related cell culture and drug screening
Tang, Q., Li, X., Chen, L., Li, L., Wu, H., Wang, Y., & Shi, X. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.07.016 · Cited by 94
Time‐Sequential and Multi‐Functional 3D Printed MgO 2 /PLGA Scaffold Developed as a Novel Biodegradable and Bioactive Bone Substitute for Challenging Postsurgical Osteosarcoma Treatment
Li, C., Zhang, W., Nie, Y., Du, X., Huang, C., Li, L., Long, J., Wang, X., Tong, W., Qin, L., et al. (2023) · Advanced Materials · doi:10.1002/adma.202308875 · Cited by 94
Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
Regan, D. P., Chow, L., Das, S., Haines, L., Palmer, E., Kurihara, J. N., Coy, J. W., Mathias, A., Thamm, D. H., Gustafson, D. L., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2105 · Cited by 92
Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma
Huang, X., Chen, J., Wu, W., Yang, W., Zhong, B., Qing, X., & Shao, Z. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.009 · Cited by 92
Bone marrow‐derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition
Pietrovito, L., Leo, A., Gori, V., Lulli, M., Parri, M., Becherucci, V., Piccini, L., Bambi, F., Taddei, M. L., & Chiarugi, P. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12189 · Cited by 91
KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma
Jiang, Y., Li, F., Gao, B., Ma, M., Chen, M., Wu, Y., Zhang, W., Sun, Y., Liu, S., & Shen, H. (2021) · Theranostics · doi:10.7150/thno.53347 · Cited by 92
Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma
Chen, L., Liu, J.-F., Lu, Y., He, X., Zhang, C., & Zhou, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.642144 · Cited by 90
Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity
Liu, K., Liao, Y., Zhou, Z., Zhang, L., Jiang, Y., Lu, H., Xu, T., Dong, Y., Gao, Q., Li, Z., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121383 · Cited by 90
MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues
Gonzalez-Molina, J., Gramolelli, S., Liao, Z., Carlson, J. W., Ojala, P. M., & Lehti, K. (2019) · Cells · doi:10.3390/cells8090991 · Cited by 89
Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
Luo, Z.-W., Liu, P.-P., Wang, Z.-X., Chen, C.-Y., & Xie, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.586580 · Cited by 89
SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex
Zhao, S.-J., Jiang, Y.-Q., Xu, N.-W., Li, Q., Zhang, Q., Wang, S.-Y., Li, J., Wang, Y.-H., Zhang, Y., Jiang, S., et al. (2017) · Oncogene · doi:10.1038/onc.2017.403 · Cited by 89
Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
Li, J., Rao, B., Yang, J., Liu, L., Huang, M., Liu, X., Cui, G., Li, C., Han, Q., Yang, H., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00769 · Cited by 89
The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation
Li, Y., Wagner, E. R., Yan, Z., Wang, Z., Luther, G. A., Jiang, W., Ye, J., Wei, Q., Wang, J., Zhao, L., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438591 · Cited by 88
Dioscin inhibits the growth of human osteosarcoma by inducing G2/M‐phase arrest, apoptosis, and GSDME‐dependent cell death in vitro and in vivo
Ding, Q., Zhang, W., Cheng, C., Mo, F., Chen, L., Peng, G., Cai, X., Wang, J., Yang, S., & Liu, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29197 · Cited by 87
RANKL blockade prevents and treats aggressive osteosarcomas
Chen, Y., Grappa, M. A. D., Molyneux, S. D., McKee, T. D., Waterhouse, P. D., Penninger, J. M., & Khokha, R. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0295 · Cited by 90
Polarization and function of tumor-associated macrophages mediate graphene oxide-induced photothermal cancer therapy
Deng, X., Liang, H., Yang, W., & Shao, Z. (2020) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2020.111913 · Cited by 86
Canine sarcomas as a surrogate for the human disease
Gustafson, D. L., Duval, D. L., Regan, D. P., & Thamm, D. H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.012 · Cited by 85
From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma
Dean, D. C., Shen, S., Hornicek, F. J., & Duan, Z. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9763-8 · Cited by 86
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
He, C., Sun, J., Liu, C., Jiang, Y., & Hao, Y. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0605-x · Cited by 86
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment
Guan, Y., Zhang, W., Mao, Y., & Li, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02161-1 · Cited by 89
Hypoxia-induced autophagy as an additional mechanism in human osteosarcoma radioresistance
Feng, H., Wang, J., Chen, W., Shan, B., Guo, Y., Xu, J., Wang, L., Guo, P., & Zhang, Y. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.001 · Cited by 86
Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma
Hu, Q., Lei, T., Hu, Y., & Lei, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673827 · Cited by 83
The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma
Niu, J., Yan, T., Guo, W., Wang, W., Ren, T., Huang, Y., Zhao, Z., Yu, Y., Chen, C., Huang, Q., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2150003 · Cited by 83
Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets
Jackson, T. M., Bittman, M. E., & Granowetter, L. (2016) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2016.04.002 · Cited by 82
miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
Ji, Q., Xu, X., Li, L., Goodman, S. B., Bi, W., Xu, M., Xu, Y., Fan, Z., Maloney, W. J., Ye, Q., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.499 · Cited by 82
The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases
Kolb, A. D., & Bussard, K. M. (2019) · Cancers · doi:10.3390/cancers11071020 · Cited by 92
The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma
Gao, Y.-Y., Ling, Z., Zhu, Y.-R., Shi, C., Wang, Y., Zhang, X.-Y., Zhang, Z.-Q., Jiang, Q. L., Chen, M., Yang, S., et al. (2021) · Theranostics · doi:10.7150/thno.55655 · Cited by 80

Authors: Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M.
Affiliations: The University of Melbourne (AU)
The University of Queensland (AU)
Garvan Institute of Medical Research (AU)
Corresponding author: Thomas, David M.
ORCID: Kansara, Maya
Teng, Michele W.
Smyth, Mark J.
Thomas, David M.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2014-10-16
Volume: 14
Issue: 11
Pages: 722-735
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc3838
OpenAlex: W1980088710
Cited by: 1,294
References: 208
Citations by year: 2026: 66 · 2025: 130 · 2024: 134 · 2023: 155 · 2022: 161 · 2021: 173 · 2020: 152 · 2019: 86 · 2018: 66 · 2017: 74 · 2016: 65 · 2015: 29 · 2014: 2
FWCI: 9.69
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: National Health and Medical Research Council
National Medical Research Council
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: osteosarcoma, bone biology, bone homeostasis, germline predisposition, cancer genomics, chromothripsis, kataegis, genomic instability, targeted therapy, mifamurtide, immune checkpoint inhibitors, adjuvant therapy, metastatic osteosarcoma, translational research
MeSH terms: Animals, Antineoplastic Agents, Bone Development, Humans, Osteosarcoma, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Translational biology of osteosarcoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks